Home › Seizures › Illinois
Seizures clinical trials in Illinois
8 studies for Seizures are looking for participants at sites in Illinois.
Cities in Illinois
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Re:Cognition Health, Chicago
RecruitingPhase 3
Ages 2 to 55 · All sexes · Updated Oct 2, 2026 · NCT05066217A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- Northwestern University, Chicago
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Oct 2, 2026 · NCT07233239RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Southern Illinois University School of Medicine, Springfield
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Oct 1, 2026 · NCT06798896Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Re:Cognition Health-Chicago, Chicago
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT07594119Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RecruitingObservational study
Up to age 26 · All sexes · Updated Aug 6, 2026 · NCT05374824A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
- Praxis Research Site, Chicago
RecruitingPhase 3
1 Day – 18 Years · All sexes · Updated Aug 3, 2026 · NCT07019922Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Rush University Medical Center, Chicago
- University of Chicago, Chicago
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jun 9, 2026 · NCT05135091A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Southern Illinois University School of Medicine, Springfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT05716100From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.